��ɫ��

��ɫ��

Events

Resources For

Abstract Details

Title mSOD1[sup]G93A[/sup] Binds Microglial CD14/TLRs Inducing a Novel Mechanism for Microglia-Mediated Motoneuron Injury

Topic Anterior Horn

Presentation(s) (-)

Poster/Presentation
Number 003

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Weihua Zhao, MD (Houston Methodist Neurological Institute, Houston Methodist Hospital)	No disclosure on file
David R. Beers, PhD (Houston Methodist Neurological Institute)	No disclosure on file
Jenny Henkel, PhD	No disclosure on file
Wei Zhang (Beijing Novartis Pharma Ltd)	No disclosure on file
	No disclosure on file
	No disclosure on file
Jean P. Julien, PhD, BSC (Montreal General Hospital Research Inst)	No disclosure on file
Stanley H. Appel, MD, FAAN (Methodist Neurological Institute)	Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.